Delivery Order SPE2DB20D7066-SPE2DB25FC4XH
- Not listed
- The Defense Logistics Agency awarded a $10,788.64 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with completion scheduled for September 22, 2025. This contract utilized firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,451.13 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on July 23, 2025, with completion scheduled for July 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $1,330.26. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.78 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,089.54 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for ultimate completion on August 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml with a ceiling value of $2,177.06. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The contract is scheduled for ultimate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,832.00 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5 mL units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award was issued on August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5ml quantities, with a ceiling value of $9,283.58 and a completion date of July 30, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4XHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,183.28 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on September 24, 2025, with completion targeted for September 25, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, supports federal medical procurement needs through AmerisourceBergen's pharmaceutical distribution capabilities. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle providing a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply requirements across multiple therapeutic domains, positioning the company as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 9/24/25 |